Gilead Sciences, Inc (NASDAQ: GILD) is -1.48% lower on its value in year-to-date trading and has touched a low of $62.07 and a high of $98.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GILD stock was last observed hovering at around $89.94 in the last trading session, with the day’s gains setting it 1.06%.
Currently trading at $91.00, the stock is -0.89% and -0.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.42 million and changing 1.18% at the moment leaves the stock 16.30% off its SMA200. GILD registered 6.57% gain for a year compared to 6-month gain of 28.51%. The firm has a 50-day simple moving average (SMA 50) of $91.7142 and a 200-day simple moving average (SMA200) of $78.15295.
The stock witnessed a -1.49% loss in the last 1 month and extending the period to 3 months gives it a 7.12%, and is -0.25% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.91% over the week and 1.91% over the month.
Gilead Sciences, Inc (GILD) has around 18000 employees, a market worth around $113.41B and $28.27B in sales. Current P/E ratio is 1025.93 and Fwd P/E is 12.03. Profit margin for the company is 0.45%. Distance from 52-week low is 46.61% and -7.99% from its 52-week high. The company has generated returns on investments over the last 12 months (0.32%).
with sales reaching $7.15B over the same period.The EPS is expected to shrink by -34.77% this year, but quarterly earnings will post 4.36% year-over-year. Quarterly sales are estimated to grow 0.51% in year-over-year returns.
Gilead Sciences, Inc (GILD) Top Institutional Holders
2357.0 institutions hold shares in Gilead Sciences, Inc (GILD), with institutional investors hold 88.43% of the company’s shares. The shares outstanding are 1.25B, and float is at 1.24B with Short Float at 2.06%. Institutions hold 88.33% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 120.63 million shares valued at $8.28 billion. The investor’s holdings represent 9.6738% of the GILD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 115.26 million shares valued at $7.91 billion to account for 9.2431 of the shares outstanding. The other top investors are CAPITAL WORLD INVESTORS which holds 76.25 million shares representing 6.1147% and valued at over $5.23 billion, while CAPITAL RESEARCH GLOBAL INVESTORS holds 4.8458 of the shares totaling 60.43 million with a market value of $4.15 billion.
Gilead Sciences, Inc (GILD) Insider Activity
The most recent transaction is an insider purchase by GILEAD SCIENCES, INC., the company’s 10% Owner. SEC filings show that GILEAD SCIENCES, INC. bought 940,499 shares of the company’s common stock on Dec 19 ’24 at a price of $21.37 per share for a total of $20.1 million. Following the purchase, the insider now owns 2.21 million shares.
Gilead Sciences, Inc disclosed in a document filed with the SEC on Dec 18 ’24 that GILEAD SCIENCES, INC. (10% Owner) bought a total of 1,759,978 shares of the company’s common stock. The trade occurred on Dec 18 ’24 and was made at $1.04 per share for $1.83 million. Following the transaction, the insider now directly holds 9.11 million shares of the GILD stock.
Still, SEC filings show that on Dec 16 ’24, Dickinson Andrew D (Chief Financial Officer) disposed off 8,500 shares at an average price of $91.96 for $0.78 million. The insider now directly holds 132,373 shares of Gilead Sciences, Inc (GILD).
